Verrà aperta una nuova finestra

Digital Genetic Counseling Platform

Identificativo proposta:TOIT20211124001

An Italian no-profit SME released a digital platform which provides specific support in the field of Genetic diseases and DNA analyses. The platform is based on innovative Artificial Intelligence tools, ad-hoc developed for virtualising the counselling process of patients affected by genetic diseases. It is embedded with secure communication protocols. The SME is mainly looking for commercial and license agreement, bioinformatics skills are also welcome. The target countries are all of Europe.


The Italian SME is providing services and strengthening project management for stakeholders involved in the sector of Genetics and genomics, such as clinical facilities, Patient advocacy organizations of rare diseases, Laboratories for molecular analyses, and research centers. Its background and technology skills focus on: biomedical research, bioinformatics, IT, eHealth, and Genetic counseling. Moreover the SME has also involved in Telemedicine services. The company has already experienced relevant research projects (at both national and International level) dealing with the above mentioned field and technologies. The offered service is a web-based AI platform aimed at digitalizing the relationship between patients and healthcare providers for Genetic diseases. The platform is designed to help deliver Genetic health and lei patients to have a better understanding of DNA tests results and what they mean. The platform can be fully customized for develop customer tailored solutions: these services can be easily applied for clinicians, healthcare organization and patients. Private and public companies (such as hospitals and academia) are the preferred partners. The company is looking for commercial or licence agreement, with the possibility to explore International marketing. Possible license agreement are considered in order the partner can use the services to develop tailore-made applications. Company is also interested in getting in contact with agents for establish commercial partnership for technical assistance.

Collaborazione prevalente

Stadio di sviluppoAlready on the market
Commenti sullo stadio di sviluppoThe platform has been released on september 2021 and has been awarded with a Prize for "digital excellence".
Stato Diritti proprietà (IPR)Patent(s) applied for but not yet granted
Commenti sullo stato dei diritti
Area di collaborazione- Type of partner sought: SMEs, Big Companies, private and public Hospitals, healthcare providers, Patient Advocacy Organizations (PAO) and Universities. - Large company and private and public partners are desired for licence agreements. - Specific area of activity of the partner: Genetic diseases. - Tasks to be performed: International marketing. The partner could also use the platform to build new applications, or integrate it in existing ones.
Collaborazione richiesta

Proponente

Tipo e DimensioneIndustry SME 11-49
Fatturato<1M
Anno inizio attività2015
Esperienza transnazionaleNo

Ambiti tecnologici

  • Tecnologie mediche / Biomediche

    SCIENZE BIOLOGICHE / Medicina e salute umana

  • Ricerca medica

    SCIENZE BIOLOGICHE / Medicina e salute umana

  • Infrastrutture per le scienze sociali e umane

    SCIENZE SOCIALI ED ECONOMICHE

Allegati

#Anteprima fileNome file
Nessun risultato trovato